Shattuck Labs, Inc. (STTK)
NASDAQ: STTK · IEX Real-Time Price · USD
7.92
+0.08 (0.96%)
At close: May 17, 2024, 4:00 PM
8.20
+0.28 (3.60%)
After-hours: May 17, 2024, 5:36 PM EDT
Shattuck Labs Revenue
Shattuck Labs had revenue of $2.72M in the twelve months ending March 31, 2024, with 282.93% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $1.12M with 1,856.14% year-over-year growth. In the year 2023, Shattuck Labs had annual revenue of $1.66M with 154.14% growth.
Revenue (ttm)
$2.72M
Revenue Growth
+282.93%
P/S Ratio
138.27
Revenue / Employee
$36,200
Employees
75
Market Cap
375.41M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.66M | 1.01M | 154.14% |
Dec 31, 2022 | 652.00K | -29.37M | -97.83% |
Dec 31, 2021 | 30.02M | 20.08M | 202.16% |
Dec 31, 2020 | 9.93M | 47.00K | 0.48% |
Dec 31, 2019 | 9.89M | -12.56M | -55.94% |
Dec 31, 2018 | 22.44M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionSTTK News
- 4 days ago - Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the European Hematology Association (EHA) 2024 Congress - GlobeNewsWire
- 16 days ago - Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights - GlobeNewsWire
- 5 weeks ago - Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024 - GlobeNewsWire
- 6 weeks ago - Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 2 months ago - Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D. - GlobeNewsWire
- 2 months ago - Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Shattuck Labs Announces Participation in Upcoming March Conferences - GlobeNewsWire
- 3 months ago - Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins - PRNewsWire